Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Spiegel S Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818441
Ancellin N and Hla T Switching intracellular signaling pathways to study sphingosine 1-phosphate receptors. 2000 Ann. N. Y. Acad. Sci. pmid:10818459
Yamamura S et al. Sphingosine-1-phosphate inhibits haptotactic motility by overproduction of focal adhesion sites in B16 melanoma cells through EDG-induced activation of Rho. 2000 Ann. N. Y. Acad. Sci. pmid:10818470
Gallois C et al. Endothelin-1 stimulates sphingosine kinase in human hepatic stellate cells. A novel role for sphingosine-1-P as a mediator of growth inhibition. 2000 Ann. N. Y. Acad. Sci. pmid:10818472
Gennero I et al. Effect of sphingosine-1-phosphate and analogues of lysophosphatidic acid on mesangial cell proliferation. 2000 Ann. N. Y. Acad. Sci. pmid:10818478
Alessenko AV The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death. 2000 Membr Cell Biol pmid:10779176
Miura Y et al. Rho-mediated phosphorylation of focal adhesion kinase and myosin light chain in human endothelial cells stimulated with sphingosine 1-phosphate, a bioactive lysophospholipid released from activated platelets. 2000 J. Biochem. pmid:10788802
Im DS et al. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. 2000 J. Biol. Chem. pmid:10799507
Parrill AL et al. Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate. 2000 J. Biol. Chem. pmid:10982820
Davaille J et al. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts. A cyclooxygenase-2 mediated pathway. 2000 J. Biol. Chem. pmid:10942778
Pitson SM et al. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. 2000 J. Biol. Chem. pmid:10944534
Nugent D and Xu Y Sphingosine-1-phosphate: characterization of its inhibition of platelet aggregation. 2000 Platelets pmid:10938902
Young KW et al. Effect of dimethylsphingosine on muscarinic M(3) receptor signalling in SH-SY5Y cells. 2000 Eur. J. Pharmacol. pmid:10940357
Bischoff A et al. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. 2000 Br. J. Pharmacol. pmid:10952677
Yamazaki Y et al. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. 2000 Biochem. Biophys. Res. Commun. pmid:10679247
Lee H et al. Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. 2000 Am. J. Physiol., Cell Physiol. pmid:10712250
Motohashi K et al. Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate. 2000 FEBS Lett. pmid:10692584
Sugiyama A et al. Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. 2000 Cardiovasc. Res. pmid:10727660
Nanjundan M and Possmayer F Characterization of the pulmonary N-ethylmaleimide-insensitive phosphatidate phosphohydrolase. 2000 Jul-Aug Exp. Lung Res. pmid:10914334
Osawa Y et al. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. 2001 J. Immunol. pmid:11418646
Im DS et al. Characterization of the human and mouse sphingosine 1-phosphate receptor, S1P5 (Edg-8): structure-activity relationship of sphingosine1-phosphate receptors. 2001 Biochemistry pmid:11705398
Rosenfeldt HM et al. The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility. 2001 Biochem. Soc. Trans. pmid:11709084
Manggau M et al. 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. 2001 J. Invest. Dermatol. pmid:11710939
Rosenfeldt HM et al. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. 2001 FASEB J. pmid:11726541
Lampasso JD et al. Sphingosine-1-phosphate effects on PKC isoform expression in human osteoblastic cells. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728164
Hla T et al. Lysophospholipids--receptor revelations. 2001 Science pmid:11729304
Muraki K and Imaizumi Y A novel function of sphingosine-1-phosphate to activate a non-selective cation channel in human endothelial cells. 2001 J. Physiol. (Lond.) pmid:11731576
Lee MJ et al. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. 2001 Mol. Cell pmid:11583630
Li G et al. Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. 2001 Development pmid:11566853
Bischoff A et al. Nifedipine inhibits sphinogosine-1-phosphate-induced renovascular contraction in vitro and in vivo. 2001 Naunyn Schmiedebergs Arch. Pharmacol. pmid:11534858
Robert P et al. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. 2001 J. Mol. Cell. Cardiol. pmid:11549339
Marletta MA Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated? 2001 Trends Biochem. Sci. pmid:11551775
Ohmori T et al. G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate: possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. 2001 J. Biol. Chem. pmid:11056155
Erl W and Siess W Sphingosine-1-phosphate and the leading Edg-1 of vascular smooth muscle cells. 2001 Circ. Res. pmid:11557732
Malek RL et al. Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. 2001 J. Biol. Chem. pmid:11069896
Tosaka M et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. 2001 Stroke pmid:11739995
Schwartz BM et al. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. 2001 Gynecol. Oncol. pmid:11330965
Hobson JP et al. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. 2001 Science pmid:11230698
Alderton F et al. Tethering of the platelet-derived growth factor beta receptor to G-protein-coupled receptors. A novel platform for integrative signaling by these receptor classes in mammalian cells. 2001 J. Biol. Chem. pmid:11359779
Pébay A et al. Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts. 2001 Eur. J. Neurosci. pmid:11422447
Kimura T et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. 2001 J. Biol. Chem. pmid:11427538
Ishii I et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. 2001 J. Biol. Chem. pmid:11443127
Kralik SF et al. A method for quantitative extraction of sphingosine 1-phosphate into organic solvent. 2001 Anal. Biochem. pmid:11444818
Wells CD et al. Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor. 2001 J. Biol. Chem. pmid:11384980
Liu F et al. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415936
Olorundare OE et al. Assembly of a fibronectin matrix by adherent platelets stimulated by lysophosphatidic acid and other agonists. 2001 Blood pmid:11418470
Repp H et al. Activation of a Ca2+-dependent K+ current in mouse fibroblasts by sphingosine-1-phosphate involves the protein tyrosine kinase c-Src. 2001 Naunyn Schmiedebergs Arch. Pharmacol. pmid:11284444
Ruwisch L et al. An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials. 2001 Naunyn Schmiedebergs Arch. Pharmacol. pmid:11284453
Tilly JL Emerging technologies to control oocyte apoptosis are finally treading on fertile ground. 2001 ScientificWorldJournal pmid:12805661
Blaukat A and Dikic I Activation of sphingosine kinase by the bradykinin B2 receptor and its implication in regulation of the ERK/MAP kinase pathway. 2001 Biol. Chem. pmid:11258664